Michael Griffin
Stock Analyst at Citigroup
(2.94)
# 1,587
Out of 4,711 analysts
13
Total ratings
80%
Success rate
21.91%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Griffin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CBRE CBRE Group | Maintains: Buy | $130 → $160 | $129.16 | +23.88% | 5 | Nov 25, 2024 | |
| AHR American Healthcare REIT | Initiates: Neutral | $14 | $27.75 | -49.55% | 1 | Mar 4, 2024 | |
| JLL Jones Lang LaSalle | Maintains: Neutral | $178 | $252.74 | -29.57% | 3 | Sep 18, 2023 | |
| HR Healthcare Realty Trust | Maintains: Neutral | $19 → $17 | $16.88 | +0.71% | 2 | Aug 22, 2023 | |
| HPP Hudson Pacific Properties | Maintains: Neutral | $5 → $4.5 | $2.93 | +53.58% | 2 | May 19, 2023 |
CBRE Group
Nov 25, 2024
Maintains: Buy
Price Target: $130 → $160
Current: $129.16
Upside: +23.88%
American Healthcare REIT
Mar 4, 2024
Initiates: Neutral
Price Target: $14
Current: $27.75
Upside: -49.55%
Jones Lang LaSalle
Sep 18, 2023
Maintains: Neutral
Price Target: $178
Current: $252.74
Upside: -29.57%
Healthcare Realty Trust
Aug 22, 2023
Maintains: Neutral
Price Target: $19 → $17
Current: $16.88
Upside: +0.71%
Hudson Pacific Properties
May 19, 2023
Maintains: Neutral
Price Target: $5 → $4.5
Current: $2.93
Upside: +53.58%